Perioperative Hyper-coagulation and Thrombosis: Cost Analysis After Congenital Heart Surgery
Pediatric Cardiology · 2025
DOI: 10.1007/s00246-024-03554-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Cardiology, 2025. Verfasst von Puja Dutta und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery, Boston Children's Hospital, Boston, MA, USA. Hauptthemen laut MEDLINE: Heart Defects, Congenital, Thrombosis, Cardiac Surgical Procedures, Postoperative Complications. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Thrombosis, a major adverse event of congenital heart surgery, has been associated with poor outcomes. We hypothesized that in CHD patients undergoing cardiac surgery, increased perioperative use of pro-coagulant products may be associated with postoperative thrombosis in the setting of hyperfibrinogenemia, leading to greater hospital and blood product costs. Single-center retrospective study. Data from Boston Children’s Hospital’s electronic health record database was used in this study. All patients undergoing congenital heart surgery between 2015 and 2018 with postoperative fibrinogen levels above 400 mg/dl were reviewed. Of 334 patients with high plasma fibrinogen levels, 28 (8.4%) developed postoperative thrombosis (median age: one year, 59% male). In our cohort, 25 (7%) demonstrated evidence of baseline hypercoagulability by one or more panel test results. Thrombosis was associated with greater hospital and blood product costs, longer ventilation times, and longer hospital and ICU length of stays. Preoperative hypercoagulable state (odds ratio: 2.58, 95% CI [1.07, 9.99], p = 0.002), postoperative red blood cell transfusion (odds ratio: 1.007, 95% CI [1.000, 1.015], p = 0.04), and single ventricle physiology (univariate odds ratio: 2.94, 95% CI [1.09, 7.89], p = 0.03) were predictors of postoperative thrombosis. Preoperative hypercoagulable state and intraoperative platelet transfusion were predictors of hospital cost. Thrombosis was associated with worse in-hospital outcomes and higher costs. Preoperative hypercoagulable state and postoperative red blood cell transfusion were significant predictors of thrombosis. Risk prediction models that can guide thrombosis prevention are needed to improve outcomes of patients undergoing congenital heart surgery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiac Surgery, Boston Children's Hospital, Boston, MA, USA.
- Department of Surgery, Harvard Medical School, Boston, MA, USA.
- Division of Cardiac Anesthesia, Department of Anesthesiology, Critical Care, and Pain Medicine, Boston Children's Hospital, 300 Longwood Ave, Boston, MA, 02215, USA. Juan.Ibla@childrens.harvard.edu.
- Department of Anesthesia, Harvard Medical School, Boston, MA, USA. Juan.Ibla@childrens.harvard.edu.
Zitieren
APA
Dutta, P., Nathan, M., Emani, S. M., Emani, S., & Ibla, J. C. (2025). Perioperative Hyper-coagulation and Thrombosis: Cost Analysis After Congenital Heart Surgery. Pediatric Cardiology. https://doi.org/10.1007/s00246-024-03554-1
Vancouver
Dutta P, Nathan M, Emani SM, Emani S, Ibla JC. Perioperative Hyper-coagulation and Thrombosis: Cost Analysis After Congenital Heart Surgery. Pediatric Cardiology. 2025. doi:10.1007/s00246-024-03554-1
BibTeX
@article{Dutta2025,
author = {Dutta, Puja and Nathan, Meena and Emani, Sitaram M and Emani, Sirisha and Ibla, Juan C},
title = {Perioperative Hyper-coagulation and Thrombosis: Cost Analysis After Congenital Heart Surgery},
journal = {Pediatric Cardiology},
year = {2025},
doi = {10.1007/s00246-024-03554-1}
}
EUVIMED